Trial Profile
A physician-initiated study to investigate the safety and efficacy of bupivacaine (Exparel) in patients undergoing open ventral hernia repair or laparoscopic colon resection
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jan 2015
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Adverse reactions; Therapeutic Use
- 05 Jan 2015 New trial record